default author photo

Daniel Spinosa

University of Colorado Anschutz Medical Campus

SCHOLARLY PAPERS

1

DOWNLOADS

27

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Bevacizumab Beyond Progression: Impact of Subsequent Bevacizumab Re-Treatment in Patients with Ovarian, Fallopian Tube, and Peritoneal Cancer after Progression

Number of pages: 25 Posted: 08 Oct 2024
affiliation not provided to SSRN, affiliation not provided to SSRN, University of Colorado Anschutz Medical Campus, University of Texas at Houston - MD Anderson Cancer Center, Duke University - Medical Center, Columbia University College of Physicians and Surgeons, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, affiliation not provided to SSRN, Duke University and University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine
Downloads 27 (1,359,097)

Abstract:

Loading...

ovarian cancer, fallopian tube cancer, bevacizumab, angiogenesis inhibitors